Cymbalta (duloxetine) is a serotonin-norepinephrine reuptake inhibitor (SNRI) approved for major depressive disorder, generalized anxiety disorder, fibromyalgia, diabetic neuropathy, and chronic musculoskeletal pain. Its dual mechanism — increasing both serotonin and norepinephrine — makes it particularly useful when depression or anxiety co-occurs with chronic pain. Understanding Cymbalta's side effects helps you weigh its benefits against potential drawbacks.
The most frequently reported side effects include nausea (the most common side effect, affecting up to 25% of patients — usually worst in the first 1-2 weeks and often mitigated by taking duloxetine with food), dry mouth, constipation, fatigue or drowsiness, decreased appetite, increased sweating, dizziness, and sexual dysfunction (decreased libido, delayed orgasm, erectile difficulties — similar rates to SSRIs). Some patients experience activation symptoms (insomnia, anxiety, agitation) particularly at treatment initiation, while others find duloxetine sedating — individual response varies significantly.
Cymbalta is known for having one of the more challenging discontinuation profiles among antidepressants. Stopping duloxetine abruptly — or even tapering too quickly — can cause dizziness, nausea, headache, irritability, "brain zaps" (electrical shock-like sensations in the head), insomnia, and flu-like symptoms. These symptoms can persist for days to weeks. The discontinuation difficulty is related to duloxetine's relatively short half-life (12 hours) and the lack of available capsule strengths for gradual tapering. If you need to stop Cymbalta, work closely with your psychiatrist on a very gradual taper schedule.
Cymbalta is an excellent choice when depression or anxiety co-occurs with chronic pain conditions (fibromyalgia, neuropathy, chronic musculoskeletal pain), because the norepinephrine component provides analgesic benefits that SSRIs lack. It may also be preferred when SSRIs have been ineffective (the dual mechanism provides broader neurotransmitter coverage), when fatigue is a prominent symptom (norepinephrine enhances alertness and energy in some patients), and for diabetic patients with neuropathic pain plus depression. A psychiatric evaluation helps determine whether duloxetine's dual mechanism suits your clinical profile, weighing its benefits against the discontinuation challenge.
This content is for informational purposes only and should not replace professional medical advice, diagnosis, or treatment. To discuss antidepressant options, contact Elevate Psychiatry. We serve adults 18 and older through our Miami offices in Coconut Grove and Doral, as well as virtually throughout Florida.
